Epstein Secrets

https://www.nytimes.corn/2020/09/02/opinion/coronavirus-convalescent-plasma.html> (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evidence." Lamas writes that possible treatments must undergo clinical tria

tion- charges-trial-delay-20200902-m3fgepntn25gs5hvy4hopbjfouq-story.html> (9/2, Meisner, 2.65M) reports, "The sweeping racketeering charges against Chicago Ald. Edward Burke may not go to trial until 2022 due to the ongoing pandemic and what Burke's lawyers call a `staggering' amount of evidence yet to be t

or Efficacy Or Safety Of Convalescent Plasma. In an op-ed for the New York Times (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evidence." Lamas writes that possible treatments must undergo clinical tria

lderman Burke Could Be Delayed To 2020 Amid Pandemic. The Chicago Tribune (9/2, Meisner, 2.65M) reports, "The sweeping racketeering charges against Chicago Ald. Edward Burke may not go to trial until 2022 due to the ongoing pandemic and what Burke's lawyers call a 'staggering' amount of evidence yet to be t

or Efficacy Or Safety Of Convalescent Plasma. In an op-ed for the New York Times (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evidence." Lamas writes that possible treatments must undergo clinical tria

lderman Burke Could Be Delayed To 2020 Amid Pandemic. The Chicago Tribune (9/2, Meisner, 2.65M) reports, "The sweeping racketeering charges against Chicago Ald. Edward Burke may not go to trial until 2022 due to the ongoing pandemic and what Burke's lawyers call a 'staggering' amount of evidence yet to be t